A vs ABCL: Which Stock is Better?
Side-by-side comparison of Agilent Technologies Inc and Abcellera Biologics Inc in 2026
A
Agilent Technologies Inc
$118.25
ABCL
Abcellera Biologics Inc
$3.86
Key Metrics Comparison
| Metric | A | ABCL | Winner |
|---|---|---|---|
| Market Cap | $33.88B | $1.11B | A |
| P/E Ratio | 26.62 | N/A | A |
| EPS (TTM) | $4.50 | $N/A | A |
| Revenue Growth | 0.1% | 7.9% | ABCL |
| Gross Margin | 52.3% | -148.7% | A |
Analyze A
Full quant analysis
Analyze ABCL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is A or ABCL a better investment?
Comparing A and ABCL: Agilent Technologies Inc has a market cap of $33.88B while Abcellera Biologics Inc has $1.11B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between A and ABCL?
A (Agilent Technologies Inc) and ABCL (Abcellera Biologics Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: A or ABCL?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: A or ABCL?
ABCL has higher revenue growth at 7.9% vs 0.1% for A.
Which company is more profitable: A or ABCL?
Agilent Technologies Inc (A) has higher gross margins at 52.3% compared to -148.7% for ABCL.
Which is the larger company: A or ABCL?
Agilent Technologies Inc (A) is larger with a market cap of $33.88B compared to $1.11B for ABCL.
Should I buy A or ABCL in 2026?
Both A and ABCL have investment merit. A trades at $118.25 while ABCL trades at $3.86. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between A and ABCL stock?
Key differences: Market Cap ($33.88B vs $1.11B), P/E Ratio (26.6x vs N/A), Revenue Growth (0.1% vs 7.9%), Gross Margin (52.3% vs -148.7%).